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ABSTRACT MicroRNAs (miRNAs) play regulatory roles in diverse processes in both eukaryotic hosts and their viruses, yet funda-
mental questions remain about which viruses code for miRNAs and the functions that they serve. Simian foamy viruses (SFVs)
of OldWorld monkeys and apes can zoonotically infect humans and, by ill-definedmechanisms, take up lifelong infections in
their hosts. Here, we report that SFVs encode multiple miRNAs via a noncanonical mode of biogenesis. The primary SFVmiRNA
transcripts (pri-miRNAs) are transcribed by RNA polymerase III (RNAP III) and take multiple forms, including some that are
cleaved by Drosha. However, these miRNAs are generated in a context-dependent fashion, as longer RNAP II transcripts span-
ning this region are resistant to Drosha cleavage. This suggests that the virus may avoid any fitness penalty that could be associ-
ated with viral genome/transcript cleavage. Two SFVmiRNAs share sequence similarity and functionality with notable host
miRNAs, the lymphoproliferative miRNAmiR-155 and the innate immunity suppressor miR-132. These results have important
implications regarding foamy virus biology, viral miRNAs, and the development of retroviral-based vectors.
IMPORTANCE Fundamental questions remain about which viruses encode miRNAs and their associated functions. Currently, few
natural viruses with RNA genomes have been reported to encode miRNAs. Simian foamy viruses are retroviruses that are preva-
lent in nonhuman host populations, and some can zoonotically infect humans who hunt primates or work as animal caretakers.
We identify a cluster of miRNAs encoded by SFV. Characterization of these miRNAs reveals evolutionarily conserved, uncon-
ventional mechanisms to generate small RNAs. Several SFVmiRNAs share sequence similarity and functionality with host miR-
NAs, including the oncogenic miRNAmiR-155 and innate immunity suppressor miR-132. Strikingly, unrelated herpesviruses
also tap into one or both of these same regulatory pathways, implying relevance to a broad range of viruses. These findings pro-
vide new insights with respect to foamy virus biology and vectorology.
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Simian foamy viruses (SFVs) are complex retroviruses belong-ing to the family Spumaretrovirinae that infect a variety of
primate hosts (1). Although endemic infection of human popula-
tions by FVs has not been observed, zoonotic transmission of SFVs
to humans may occur through hunting and butchering of some
nonhuman primates, as well as through injuries sustained by care-
givers in zoos and animal research facilities (2–7). SFVs do not
currently have disease associations in the context of infections
endemic to primates or zoonotic human infections, yet they are
capable of establishing long-term persistent infections (8, 9).
However, a complete mechanistic understanding of how SFVs are
able to evade the host immune response and maintain long-term
infections is lacking.
microRNAs (miRNAs) are small regulatory RNAs encoded by
most eukaryotes and some viruses (reviewed in references 10–13).
Diverse viruses have been shown to encode miRNAs, but the ex-
tent to which different virus families utilize miRNAs remains a
fundamental question. Furthermore, the functions of the majority
of viral miRNAs are unknown. However, several themes are
emerging from the currently available data, including optimiza-
tion of productive versus latent infection, immune evasion, and
promotion of host cell viability (11, 14). Some viral miRNAs have
been reported to achieve their functions by tapping into host reg-
ulatory networks by mimicking host miRNAs through partial se-
quence similarity (10).
We have improved a combined computational and synthetic
approach to predict miRNA genes from primary sequence infor-
mation and applied it to the foamy viruses (15). This analysis
identified clusters of candidate RNA polymerase III (RNAP III)-
transcribed miRNA genes in the long terminal repeats (LTRs) of
SFVs and some FVs with nonprimate hosts. We characterized
miRNAs of the African green monkey FV (SFVagm). These miR-
NAs are generated from atypical RNAP III primary transcripts.
Two of the SFVagm miRNAs share seed identity and functionality
with host miRNAs miR-132 and miR-155. The relevance of these
findings to FV biology and vectorology is discussed.
RESULTS
FVs encode miRNAs. Using a combined computational and syn-
thetic approach, we previously reported the identification and
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characterization of viral miRNAs encoded by a deltaretrovirus,
bovine leukemia virus (BLV) (15). We have subsequently modi-
fied our algorithmic approach to include new features derived
from the BLV miRNAs. These features include searching for an
RNAP III terminator sequence at the 3= base of predicted RNA
stem-loop structures and modification of the RNAP III promoter
sequences to include noncanonical A and B box sequences from
the BLV miRNAs. The new approach identified additional pre-
dicted miRNA candidates (see Data Set S1 in the supplemental
material). Two candidates from simian foamy virus of African
green monkey (SFVagm), two from simian foamy virus of rhesus
macaque (SFVmac), and one from feline foamy virus (FFV) were
chosen for further screening (Fig. 1A; see Fig. S1 in the supple-
mental material). The candidate miRNA sequences were synthe-
sized in the context of minimal bacterial plasmids. HEK293T cells
were transfected with these plasmids, and Northern blot analysis
was performed. This analysis revealed readily detectable banding
patterns consistent with the predicted primary (pri-), pre-, and
mature miRNAs (Fig. 1B; Fig. S1). Luciferase-based reporters
were used to test whether the observed small RNAs generated
from the SFVagm constructs were active in the RNA-induced si-
lencing complex (RISC). Cotransfection of these reporters with
the synthetic miRNA plasmids resulted in significant and specific
inhibition of reporter activity, indicating that the putative miR-
NAs are active in RISC (Fig. 1C).
Next, we investigated whether the miRNAs are expressed in the
context of SFVagm infection. RNA profiling was conducted on
small RNA fractions extracted from HeLa cells 3 days after infec-
tion with SFVagm (Fig. 2; see Table S1 in the supplemental mate-
rial). This analysis confirmed the expression of the computation-
ally predicted miRNAs, as well as additional viral miRNA
candidates in the U3 LTR region. Importantly, the read patterns
mapping to the SFVagm genome displayed the hallmarks of bona
fide miRNAs, including a predominant size of ~22 nucleotides
(Fig. S2A) and mapping to predicted RNA stem-loop secondary
structures with guide strand/passenger strand complementarity
offset typically by 3= overhangs, a hallmark of RNase III-like en-
zymatic processing (Fig. S2B). As an additional verification of the
RNA-seq-mapped small RNAs, Northern blot analysis was con-
ducted for each of the abundantly mapped candidates (Fig. S3).
This analysis revealed readily detectable small RNAs correspond-
ing mostly to the abundant products identified by small RNA
sequencing. However, we note that for some pre-miRNAs, such as
SFVagm-miR-S3, the 5p- and 3p-derived miRNAs showed inverse
abundance in the Northern or RNA-seq analyses (Fig. 2; Fig. S3).
We speculate that this is due to inherent sequence biases in the
RNA-seq library construction. In addition, banding patterns in-
dicating the detection of some longer transcripts are consistent
with the predicted gene architectures. Comparison of the SFVagm
miRNA sequences with those of human miRNAs revealed several
with similarity in the miRNA seed region (Table S2). The seed
region encompasses nucleotides 2 to 7 of the miRNA and is an
FIG 1 A combined computational and synthetic approach identifies SFV-encoded candidate miRNAs. (A) Diagram of predicted genetic structure and
secondary structure predictions by Mfold for two candidate miRNAs from SFVagm. Termini in diagrams have been updated to start and termination sites from
the following RNA-seq data. Mauve arrows indicate the most abundantly mapped small RNAs from RNA-seq data (Fig. 2). Yellow arrows indicate predicted
RNAP III promoter elements. Red arrows indicate predicted RNAP III terminator sequences. (B) Northern blot analysis of total RNA extracted from HEK293T
cells transfected with either negative-control empty expression vector (NC) or the indicated synthetic gene (S3, S7) constructs. Ethidium bromide-stained
low-molecular-weight (LMW) RNA is provided as a loading control. Blots were also probed for hsa-miR-19a as an additional control. nt, nucleotides. (C) RISC
reporter assays for synthetic miRNA candidate constructs. HEK293T cells were cotransfected with either empty expression vector (VEC) or the indicated
synthetic gene construct and both control firefly luciferase reporter and Renilla luciferase reporter plasmids with vector UTR (VEC) or two sites perfectly
complementary to the indicated predicted miRNA arm (S3 3p or S7 3p). The mean relative luciferase activity ratios, normalized to the results for the control
Renilla luciferase vector 3= UTR, are graphed. Error bars represent the standard deviations (SD) of three replicates.
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important determinant of canonical miRNA target interaction
(16). Therefore, we chose to focus our investigation on the candi-
date miRNAs SFVagm-miR-S4 and SFVagm-miR-S6.
Noncanonical biogenesis of SFV miRNAs. We tested our
original prediction of RNAP III-dependent transcription of the
primary miRNA transcripts (pri-miRNA). The banding patterns
detected via Northern blot analysis (Fig. 1B; see Fig. S1 and Fig. S3
in the supplemental material) and the fact that several of the SFV
miRNAs end in a stretch of Us (RNAP III terminator sequence)
(Fig. S2B) were consistent with RNAP III-mediated transcription.
We used a strategy in which plasmids containing the miRNA and
flanking sequences are transfected into HEK293T cells, followed
by treatment with-amanitin at a concentration known to inhibit
RNAP II transcription but not RNAP III transcription (17). For
controls, we utilized two characterized viral noncoding RNAs
(ncRNAs), the RNAP II-dependent HSUR4 from herpesvirus sai-
miri and the RNAP III-dependent MHV68-miR-M1-7 from
mouse gammaherpesvirus 68 (17, 18). Northern blot analysis re-
vealed that -amanitin treatment strongly inhibited the expres-
sion of HSUR4 but not MHV68-miR-M1-7 or any of the tested
SFV miRNAs (Fig. 3A). These results combined with our initial
observations are consistent with the SFV miRNAs being tran-
scribed by RNAP III.
Most host miRNAs are processed from longer primary miRNA
transcripts into smaller pre-miRNA stem-loop structures by the
Microprocessor complex (19). However, the reported BLV and
MHV68 RNAP III-transcribed miRNAs are not processed by
Drosha, the endonuclease component of Microprocessor (15, 17).
Some of the SFV candidate miRNAs have predicted BLV miRNA-
like precursor structures and gene architecture (Fig. 1A; see
Fig. S1B in the supplemental material). However, others produced
an additional, slower-migrating band by Northern analysis that is
consistent with the predicted longer primary transcript contain-
ing up to two pre-miRNA-like structures (Fig. 1A and B; Fig. S1A
and S3). To test whether the SFVagm-miR-S4 and SFVagm-
miR-S6 pri-miRNAs are processed by Drosha, we performed
small interfering RNA (siRNA) knockdown of Drosha in
HEK293T cells, followed by transfection of viral miRNA vectors
and Northern blot analysis (Fig. 3B). For controls, we included the
Drosha-dependent SV40-miR-S1 from simian virus 40 and the
Drosha-independent MHV68-miR-M1-7. As expected, Drosha
knockdown resulted in decreased SV40-miR-S1 pre-miRNA and
no significant change in MHV68-miR-M1-7 pre-miRNA. Unlike
other known viral pol III miRNAs, the tested SFV miRNAs exhib-
ited decreased pre-miRNA levels upon Drosha knockdown. Next,
we tested the effects of overexpression of Drosha and its binding
partner DGCR8. HEK293T cells were sequentially transfected first
with Drosha/DGCR8 and then with miRNA expression vectors,
followed by Northern blot analysis (Fig. 3C). As expected, Drosha/
DGCR8 overexpression resulted in an increase in SV40-miR-S1
pre-miRNA and no noticeable change in MHV68-miR-M1-7 pre-
miRNA. However, consistent with our Drosha knockdown exper-
iments described above, the overexpression of Drosha/DGCR8
resulted in increased SFV pre-miRNA. These data are consistent
with Drosha-dependent production of these SFV pre-miRNAs
from longer RNAP III transcripts.
Since the genomic region encoding the SFV miRNAs is also
transcribed by RNAP II to generate viral genomic RNA and mR-
NAs, we next tested the ability of Drosha to cleave SFV pri-
miRNAs in the context of longer RNAP II transcripts. To accom-
plish this, we utilized a Drosha cleavage efficiency assay that has
been previously described (15). SFV pri-miRNA sequences and
FIG 2 Small RNA profiling of SFVagm-infected cells reveals a cluster of miRNA candidates in the SFVagm LTR. RNA-seq analysis was performed on
size-fractionated RNA extracted from HeLa cells 72 h after infection with SFVagm. The horizontal axis indicates the genomic position relative to the SFVagm
reference genome (NC_010820). The vertical axis indicates the mapped small RNA read count (black impulses indicate start counts of RNA reads). An SFVagm
genomic organization map based on annotation in reference sequence NC_010820 is provided below the horizontal axis. Light-blue arrows indicate LTR regions,
yellow arrows indicated protein coding sequences, and dark blue arrows indicate the mapped small RNAs. Inset graph displays an enlargement of the LTR region
to provide finer detail of the candidate miRNA cluster (black impulses indicate start counts of RNA reads and red lines indicate overall coverage).
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control pri-miRNA sequences were cloned into the 3= untrans-
lated region (UTR) of Renilla luciferase reporters. These vectors
were cotransfected with control firefly luciferase reporter and ei-
ther Drosha/DGCR8 expression vectors or empty vector, and
dual-luciferase assays were performed (Fig. 3D). As expected,
overexpression of Drosha/DGCR8 resulted in significant reduc-
tion of the relative luciferase activity for the Drosha-dependent
control reporters (SV40-miR-S1 and KapB), while no significant
difference was observed for the Drosha-independent MHV68-
miR-M1-7 reporter. Remarkably, none of the tested FV pri-
miRNA constructs exhibited a decrease with Drosha/DGCR8
overexpression. These results suggest that the SFV miRNAs as-
sayed are not efficiently processed in the context of longer RNAP
II-transcribed RNAs.
Dicer is the enzyme that cleaves pre-miRNAs into mature
miRNA duplexes in the canonical miRNA biogenesis pathway. To
determine whether the SFV miRNAs were processed by the host
enzyme Dicer, DLD1 Dicer-hypomorphic cells (20) and parental
DLD1 wild-type cells were transfected with miRNA expression
vectors and Northern blot analysis was performed (Fig. 3E). The
Dicer-dependent control, MHV68-miR-M1-7, showed an in-
creased ratio of the pre-miRNA to mature miRNA. Similar ratio
changes were observed for the SFV miRNA constructs tested.
These data support Dicer-dependent processing of the SFV miR-
NAs assayed.
To dissect the genetic elements of an SFV miRNA gene, a series
of mutations were made in the predicted promoter and termina-
tor elements of SFVagm-miR-S4 (see Fig. S4A in the supplemental
material). These constructs were transfected into HEK293T cells,
and total RNA was extracted and assayed by Northern blotting
(Fig. S4B). As predicted, disruption of either the A box or B box
promoter elements resulted in decreased expression, while dis-
ruption of the terminator sequence resulted in slower-migrating
bands, consistent with read-through transcription to downstream
terminator-like sequences. It is worth noting that longer read-
through transcripts are not processed into mature miRNA se-
quences. Combined with the Drosha cleavage assay described
above (Fig. 3D), these data are consistent with SFV miRNAs not
being processed in the context of longer transcripts.
Functions of SFV miRNAs. Several other viruses, including
herpesviruses and the retrovirus BLV, have been shown to mimic
host miRNAs through seed similarity (reviewed in reference 11).
The SFVagm-encoded miR-S4-3p shares seed identity with host
miRNA miR-155 (Fig. 4A). This is notable because miR-155 is
associated with cell survival and lymphoproliferation and at least
three other herpesviruses encode analogs of this miRNA or induce
its expression (21–26). Furthermore, candidate miR-S6-3p shares
seed identity with the host miRNA family miR-132/212 (Fig. 4A),
which has been shown to be a negative regulator of innate immu-
nity that is induced by Kaposi’s sarcoma-associated herpesvirus
(KSHV) infection (27).
We first confirmed that these SFV miRNAs are active in RISC
(Fig. 4B). As expected, luciferase reporters bearing perfectly com-
plementary sequences in their 3= UTRs were specifically and ro-
bustly downregulated when cotransfected with the respective FV
miRNA expression vector. Next, to test whether the SFVagm miR-
FIG 3 Characterization of SFV miRNA biogenesis reveals noncanonical mechanisms. (A) Northern blot analysis of total RNA extracted from HEK293T cells
transfected with the indicated miRNA expression vectors and either treated or not treated with the RNAP II inhibitor -amanitin as indicated. Ethidium
bromide-stained LMW RNA is provided as a loading control. (B) Northern blot analysis of total RNA extracted from HEK293T cells transfected with the
indicated miRNA expression vectors and Drosha siRNA (siDro) or negative-control siRNA (siNC). Numbers below lanes indicate signal intensity of pre-miRNA
relative to siNC lane for each expression vector. Ethidium bromide-stained low-molecular-weight RNA is provided as a loading control. (C) Northern blot
analysis of total RNA extracted from HEK293T cells cotransfected with the indicated miRNA expression vectors and either Drosha/DGCR8 expression vectors
(D/D) or empty vector (VEC). Numbers below lanes indicate signal intensity of pre-miRNA relative to VEC lane for each expression vector. Ethidium
bromide-stained LMW RNA is provided as a loading control. (D) Drosha cleavage assay was performed on FV miRNA candidates and control miRNAs cloned
into the 3= UTR of Renilla luciferase vectors. The indicated miRNA 3= UTR vectors were cotransfected with control firefly luciferase vector and either Drosha/
DGCR8 expression vectors (D/D) or empty vector (Vector). The mean relative luciferase activity ratios, normalized to the results for the control vector Renilla
luciferase vector 3= UTR, are graphed. Error bars represent the SD of three replicates, and the P values were calculated using Student’s t test. (E) Northern blot
analysis of total RNA extracted from untransfected DLD1 (M), wild-type DLD1 (WT), or DLD1 DicerEx 5/ hypomorph (EX5-) cells transfected with the
indicated miRNA expression vectors. Numbers below lanes indicate pre-miRNA signal divided by mature miRNA signal. Ethidium bromide-stained LMW RNA
is provided as a loading control.
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NAs could target transcripts that were similar to the host miRNAs,
we used previously reported luciferase 3= UTR reporters for an
miR-155 target, BACH1 (26), and an miR-132 target, p300 (27).
Reporter vectors were cotransfected with miRNA expression vec-
tors, and dual-luciferase assays were performed (Fig. 4C). The FV
miRNAs significantly inhibited the relative luciferase activities for
the respective reporters. Similar to their host counterparts, this
regulation was specific, since the mutant reporters (containing
small disruptions in the seed-complementary regions of each re-
spective 3= UTR) reduced the viral miRNA-mediated regulation
that we observed. We next assayed protein levels by Western blot-
ting in HEK293 cells infected with SFVagm (Fig. 4D). The protein
levels of both BACH1 and p300 were significantly reduced
(40%) in cells infected with SFVagm. Although non-miRNA
factors related to viral infection likely contributed to the observed
effects, these data are consistent with direct targeting, as observed
in the reporter assays. Therefore, we conclude that SFVagm-
miR-S4 can function as an analog of host miRNA miR-155 and
SFVagm-miR-S6 can function as an analog of host miRNA miR-
132.
Host miR-132 has been identified as having a role in the down-
regulation of p300, which is a transcriptional coactivator of the
type I interferon (IFN) response (27, 28). To determine whether
miR-S6 (the viral miR-132 seed mimic) shares this functionality,
we first tested miR-S6 for the ability to alter IFN-mediated trans-
activation of an interferon-stimulated response element (ISRE)-
driven luciferase reporter. HEK239T cells were cotransfected with
either miR-S6 expression vector or positive-control (miR-132
[27] and miR-122 [29]) or negative-control (empty) vectors and
then treated with universal type I interferon. As previously pub-
lished (27, 29), both positive controls reduced ISRE activity. Im-
portantly, the expression of miR-S6 resulted in a decrease in ISRE
activity comparable to the effects of the positive controls (Fig. 5A).
Next, we used a more biological assay to further determine the
functionality of miR-S6 in regulating the IFN response. Stable
B-cell lines were generated that expressed positive-control (miR-
132) or negative-control (irrelevant Epstein-Barr virus [EBV]
miRNA EBV-miR-BART4 or empty lentivector) miRNAs or miR-
S6. Then, the growth rates of all the cell lines in either the presence
or absence of exogenously added universal type I interferon were
measured. All the cell lines grew similarly in the absence of inter-
feron (Fig. 5B). However, as we previously demonstrated (30),
treatment with IFN significantly reduced the growth rates of the
vector and irrelevant-miRNA-expressing cell lines. In contrast,
FIG 4 Some SFV-encoded miRNAs function as analogs of host miRNAs. (A) Sequence comparison of SFV miRNAs SFVagm-miR-S4-3p and SFVagm-miR-
S6-3p to miRNAs hsa-miR-155 and hsa-miR-132, respectively. The miRNA seed sequence is indicated in bold. (B) RISC reporter assays for SFVagm miRNA
candidates. HEK293T cells were cotransfected with either empty expression vector (VEC) or the indicated synthetic gene construct and both control firefly
luciferase reporter and Renilla luciferase reporter plasmids with vector UTR (VEC) or two sites perfectly complementary to the indicated predicted miRNA arm
(S4 3p or S6 3p). The mean relative luciferase activity ratios, normalized to the results for the control vector Renilla luciferase vector 3= UTR, are graphed. Error
bars represent the SD of three replicates. (C) BACH1 and p300 3= UTR reporter assays were performed. HEK293T cells were cotransfected with either empty
expression vector (VEC) or the indicated synthetic gene construct and the indicated 3= UTR reporter. The pGL3-based BACH1 reporters and empty vector
controls included cotransfection of pcDNA3.1dsLuc2CP control vector. The psiCheck2-based p300 reporters express both firefly and Renilla luciferase from the
same plasmid. The BACH1mut and p300mut vectors contain mutations in seed regions complementary to miR-155 and miR-132, respectively (26, 27). The
mean relative luciferase activity ratios, normalized to the results for the VEC control Renilla luciferase vector, are graphed. Error bars indicate SD. (D)
Immunoblot analysis of protein extracted from HEK293 cells 72 h after infection with SFV or mock infection (Mock). A representative blot for each indicated
target (BACH1 or p300) is provided, along with a blot for -actin as a loading control. Graphs represent quantification of the means of three independent
replicates relative to data for mock-infected cells. Error bars indicate SD, and P values were calculated with Student’s t test.
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both the miR-S6- and host miR-132-expressing cells had substan-
tial increases in viable cell counts compared to the viable cell
counts in the control cell lines (up to 8- and 11-fold, respectively).
These results indicate that both miR-132 and miR-S6 can provide
a growth advantage to B cells that are exposed to interferon. Com-
bined, our data show that SFVagm-miR-S6 is a functional mimic
of the IFN-suppressive host miRNA miR-132.
DISCUSSION
Over 300 viral miRNAs have been reported (31), and the complete
list of viral families that encode them remains a work in progress.
We have previously reported that the deltaretrovirus BLV encodes
a cluster of RNAP III-transcribed miRNAs (15), and these miR-
NAs were shown to be made in vivo (32). Using a refined compu-
tational and synthetic strategy, we identified candidate miRNAs in
FVs that share predicted promoter architecture similar to that of
BLV miRNAs, as well as a more canonical ordering of predicted
promoter and terminator elements (Fig. 1A; see Fig. S1 in the
supplemental material). Small RNA profiling of SFVagm-infected
cells confirmed our initial predictions and revealed additional
candidate miRNAs located in a cluster mapping to the LTR region
(Fig. 2). Thus, our work adds to the modest but increasing number
of viruses with RNA genomes known to make miRNAs.
Probing the pathways that give rise to the SFV miRNAs re-
vealed noncanonical biogenesis strategies, including longer RNAP
III transcripts which give rise to pre-miRNAs in a Drosha-
dependent manner (Fig. 3B and C). This was unanticipated, as
these pri-miRNAs are not predicted to have a canonical “base”
region that has long been associated with Microprocessor-
mediated cleavage (33, 34). Importantly, we provide evidence sug-
gesting that the processing of these SFV miRNAs is context depen-
dent, as longer RNAP II transcripts that span the miRNAs are
immune to Microprocessor activity and disruption of a termina-
tor sequence resulted in longer transcripts but undetectable
miRNA production (Fig. 3D; see Fig. S4 and S5 in the supplemen-
tal material). In this way, FVs may avoid fitness costs associated
with cleavage of genomic or mRNA transcripts. Future mechanis-
tic studies will be needed to determine why extended transcripts
are not efficiently processed and whether they are dependent on
other enzymes for their maturation. Additionally, the shorter FV
pri-miRNAs (e.g., SFVagm-miR-S3) resemble the Drosha-
independent BLV pri-miRNAs in predicted structure, but it
awaits experimental confirmation whether this class of FV miR-
NAs is also generated via a Drosha-independent mechanism.
Thus, FV transcripts represent an arena ripe for future efforts to
better understand Microprocessor pri-miRNA recognition and
processing.
Our bioinformatics results predict that similar miRNA genes
are shared among other SFVs, including the prototype foamy vi-
rus (PFV), as well as some nonprimate FVs (see Data Set S1 in the
supplemental material). Our predictions identified candidate
BLV-like miRNA genes in the feline FVs and candidate longer
miRNA genes in the bovine and equine FVs (Data Set S1). Al-
though our initial tests of a predicted FFV miRNA (Fig. S1B) were
positive, these results should only be considered provisional until
they are further validated in infected cells. However, while our
paper was under review, Whisnant et al. (35) reported miRNAs
encoded by the bovine foamy virus, suggesting shared atypical
biogenesis of some miRNAs from diverse FVs. Combined, these
observations imply that this mode of miRNA production may be
of deep evolutionary origin.
We observed similarities between the SFV miRNAs and host
miRNA families (see Table S2 in the supplemental material). One
of the most striking observations was that SFVagm-miR-S4-3p
shares seed identity and functionality with host miR-155, a noted
host oncogenic miRNA (oncomiR) (36, 37) (Fig. 4). At least two
other viruses, Marek’s disease virus type 1 (an alphaherpesvirus of
FIG 5 SFVagm-miR-S6 mimics host miR-132 in inhibition of the IFN (in-
terferon) response. (A) HEK293T cells were cotransfected with plasmids ex-
pressing an IFN-responsive firefly luciferase reporter, a transfection control
expressing Renilla luciferase from a constitutive promoter, and either an
miRNA expression plasmid (miR-122, miR-132,or S6S7) or control empty
vector (VEC). Forty-eight hours after transfection, cells were treated with
100 U/ml universal type I IFN. Twelve hours later, a dual-luciferase assay was
performed. Relative luciferase activity is normalized to the respective vector
control. The means are graphed along with error bars that represent the SD of
three replicates, and P values were calculated with Student’s t test. (B) Stable
B-cell lines expressing miR-132, EBV-miR-BART4 (miR-Ctrl), SFVagm-
miR-S6 (S6S7), or empty vector (Vector) were treated daily with 250 U/ml of
interferon ( IFN) or BSA, and viable cells (as assayed by trypan blue staining)
were counted. For all experiments, the means of three independent biological
replicates are shown and error bars indicate SD.
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birds) and KSHV (a gammaherpesvirus of humans) encode sim-
ilar mimics of miR-155, and Epstein-Barr virus (another gamma-
herpesvirus of humans) induces higher levels of host miR-155 in
infected B cells (22, 23, 25, 26). A second important observation is
that SFVagm-miR-S6-3p shares seed identity with the host
miRNA family miR-132/212. KSHV induces host miR-132 during
infection, and miR-132 suppresses innate immunity (27). In in-
dependent assays, we demonstrate that, similar to miR-132,
miR-S6 can suppress IFN-induced responses (Fig. 5). These com-
bined observations lead to the interesting hypothesis that the oth-
erwise unrelated KSHV and SFVagm have evolved independently
to tap into the same host miR-155 and miR-132 regulatory path-
ways.
FVs have been noted for having the longest LTRs of reported
retroviruses (1). Previous reports indicate that SFVs passaged in
cell culture have a propensity to undergo deletions of portions of
the U3 region of the LTR (38, 39). Interestingly, these reported
deletions are in the miRNA cluster region, and viruses with these
deletions were shown to replicate better in fibroblast cell culture
(38). These observations raise the possibility that, similar to what
has been reported for polyoma and herpesviruses (10, 11, 40, 41),
some of the FV miRNAs contribute to optimizing virus gene ex-
pression and/or the establishment of viral reservoirs and/or the
switch from latent to productive infectious cycles. It has also been
reported that an SFV is targeted by a cell type-specific host miRNA
and also encodes the protein Tas, which functions both as the viral
transactivator and as a proposed inhibitor of miRNAs (42). From
this published work, one might hypothesize that Tas could func-
tion to negatively regulate viral miRNA activity to promote/en-
hance productive infection; however, this seems unlikely given
that the miRNA-inhibitory function of Tas has failed to be inde-
pendently reproduced by other laboratories (43). Future studies
will be needed to directly address the roles of the miRNAs in virus
replication.
While FVs are not currently associated with disease states ei-
ther in nonhuman primate populations in which they are endemic
or in zoonotic human infections, our findings suggest new associ-
ations to investigate. Exogenous expression of miR-155, as well as
infection with herpesviruses that encode miR-155 analogs, has
been associated with lymphoproliferative disease (37, 44).
Whether any such disease association exists for SFVagm in its
natural host or in zoonotically infected humans remains to be
seen.
The discovery of FV miRNA genes in the LTR region may have
applications to retroviral vector development. Vector designs
should be reviewed for the unintended inclusion of viral miRNA
genes. The importance of this is further emphasized since these
viral miRNAs may function as analogs of some host immunosup-
pressive or oncogenic miRNAs. Fortunately, current-generation
FV vectors typically exclude the FV U3 region that would contain
the FV miRNAs in favor of other, chimeric sequences (45–47).
Alternatively, the SFV miRNAs provide inspiration for new archi-
tectures of small RNA transgene delivery.
In summary, we have demonstrated that SFVs encode a cluster
of viral miRNAs in their LTRs via unconventional biogenesis
mechanisms. Some of these viral miRNAs mimic host miRNAs,
including a host oncomiR, miR-155, and an innate immune sup-
pressor, miR-132. These findings have important implications for
understanding the biology of foamy viruses, zoonotic foamy in-
fections, miRNA biogenesis, and the development of FVs as vec-
tors.
MATERIALS AND METHODS
See Text S1 in the supplemental material for full details of materials and
methods used in the study.
Cell lines.HeLa, HEK293, and HEK293T cell lines were obtained from
American Type Culture Collection (ATCC) and maintained in Dulbecco
modified Eagle medium (DMEM) supplemented with 10% (vol/vol) fetal
bovine serum (FBS) and penicillin-streptomycin (Pen-Strep) (Cellgro).
Dicer wild-type cells (DLD1) and cells hypomorphic for Dicer activity
(DLD1 DicerEx5/) (20) were maintained in RPMI 1640 supplemented
with 10% (vol/vol) FBS and Pen-Strep. The human B-cell line GM19240
was obtained from the Coriell Institute and maintained in RPMI 1640
supplemented with 15% (vol/vol) FBS and Pen-Strep.
Plasmids.Plasmid constructs were generated with standard molecular
cloning techniques. See Text S1 and Data Set S2 in the supplemental
material for complete details and sequences.
Generation of stable cell lines expressing SFVagm-miR-S6S7 and
controls. Lentiviral transduction of the GM19240 cell line and selection
with puromycin were performed as previously described (30).
miRNA prediction software. Scripts and associated data will be made
freely available at https://code.google.com/p/mirna/.
Small RNA Northern blots. Small RNA Northern blot analysis was
performed as previously described (48). Band intensities were measured
using Quantity One image analysis software (Bio-Rad). Probe sequences
are listed in Data Set S2 in the supplemental material.
Preparation of FV stocks. SFVagm (SFV-HU1, ATCC VR-2596) was
amplified by serial passage on BHK21 cells. SFVagm stock titers (syncytia-
forming units per ml [SFU/ml]) were determined by serial dilution and
infection of BHK21 cells followed by staining with 0.5% (wt/vol) methyl-
ene blue and 50% methanol (vol/vol) solution and counting of syncytia.
Small RNA sequencing. Fifty-percent confluent HeLa cells in a T75
flask were infected with 5.4  104 SFU of SFVagm. Seventy-two hours
postinfection, total RNA was harvested with PIG-B (49). Two hundred
micrograms of total RNA was size fractionated on a 15% (vol/vol) urea-
PAGE gel and used to prepare pooled (45% of pooled RNA) small RNA
libraries for Illumina small RNA sequencing. Sequencing was performed
on an Illumina HiSeq 2500 at the Genomic Sequencing and Analysis Fa-
cility at the University of Texas, Austin. Postprocessing and analysis of
sequence data were carried out as previously described (30).
Precursor miRNA structure prediction. miRNA stem-loop second-
ary structures were generated using the Mfold RNA folding prediction
Web server (50, 51). RNAfold software was used in the miRNA prediction
pipeline (52).
RISC activity assay. HEK293T cells were transfected and dual-
luciferase reporter assays were performed as previously described (30).
RNA polymerase activity assay. HEK293T cells were transfected with
miRNA expression vectors as indicated. Two hours later, the cells were
treated with 50 g/ml -amanitin (Sigma-Aldrich). Total RNA was har-
vested with PIG-B (49) at 24 h posttransfection, and Northern blot anal-
ysis was performed.
Drosha siRNA assay. Small interfering RNA (siRNA) knockdown of
Drosha was followed by transfection of miRNA expression vectors in
HEK293T cells and then by Northern blot analysis as previously described
(30).
Microprocessor overexpression. Sequential transfection of
HEK293T cells with Drosha/DGCR8 vectors and miRNA expression vec-
tors, followed by Northern blot analysis, were performed as previously
described (15).
Drosha cleavage efficiency assay. Cotransfection of HEK293T cells
with miRNA expression vectors and Drosha/DGCR8 vectors was per-
formed as previously described (30).
Dicer dependence assay. Dicer wild-type cells (DLD1) and cells hy-
pomorphic for Dicer activity (DLD1 DicerEx5/) (20) were transfected
with miRNA expression vectors using the TurboFect reagent (Fermentas).
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Twenty-four hours posttransfection, total RNA was extracted with PIG-B
and Northern blot analysis was performed.
Host target 3= UTR luciferase assays. Fifty-percent-confluent
HEK293T cells in 24-well plates were cotransfected with 0.5 ng of the
indicated luciferase reporters (pGL3-based BACH1 reporters and empty-
vector controls included cotransfection with pcDNA3.1dsLuc2CP control
vector; psiCheck2-based p300 reporters express both firefly and Renilla
luciferase from the same plasmid) and 0.5 g of the indicated miRNA
expression vectors using the TurboFect reagent (Fermentas) in triplicate.
Twenty-four hours posttransfection, cells were harvested and assayed
with the Dual-Glo luciferase assay system (Promega). Luciferase activity
was measured with a Luminoskan Ascent luminometer (Thermo Elec-
tronic). Student’s t test was used to assess the statistical significance of
observed differences.
Western immunoblot analysis. Fifty-percent-confluent 6-well plates
of HeLa cells were infected with 1.35  104 SFU of SFVagm or mock
infected. Twenty-four hours later, the medium was replaced with fresh
medium. Ninety-six hours after infection, lysates were prepared as previ-
ously described (30). Fifty micrograms of the total lysate was separated in
NuPAGE 4 to 12% bis-Tris gels and transferred to nitrocellulose mem-
branes (Bio-Rad). Membranes were blocked with Odyssey blocking buffer
(Li-Cor). The primary antibodies used were p300 (C-20) (sc-585; Santa
Cruz Biotechnology), BACH1 (C-20) (sc-14700; Santa Cruz Biotechnol-
ogy), and -actin (C4) (sc-47778; Santa Cruz Biotechnology). Blots were
scanned on an Odyssey CLx infrared imaging system (Li-Cor). Band in-
tensities were measured with Image Studio software (Li-Cor). Three in-
dependent experiments were performed on different days for quantifica-
tion, and Student’s t test was used to assess the statistical significance of
observed differences.
Interferon signaling assay. HEK293T cells were seeded in 96-well
plates. The next day, 5 ng pcDNA3.1dsRluc and 20 ng pISRE-Luc
(Clonetech) were cotransfected along with 100 ng of the indicated miRNA
expression vector or control vector using the TurboFect transfection re-
agent (Fermentas). The mixture for each experimental condition was
transfected into 6 wells (2 sets of triplicates—3 control wells and 3 exper-
imental wells). After 48 h, the medium was replaced with new medium
with or without 100 U/ml of universal type I interferon (PBL Interferon
Source). Twelve hours after the IFN treatment, a dual-luciferase assay was
performed. Three independent experiments were performed, each in trip-
licate.
Interferon growth assay. Stable B-cell lines were treated with inter-
feron, and cell viability was assayed by trypan blue staining as previously
described (30). Three independent experiments were performed, each in
triplicate.
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